BNOX Tambahing bathi saben saham ing taun lumaku Bionomics Limited

BNOX (Bionomics Limited) - tandha merek perusahaan

The distribution of the annual change in earnings per share demonstrates a trend where the indicator reached the level of 65.30, which correlates with expectations following the phase 2/3 results of the BNC210 drug for Bionomics Limited (BNOX). Business stability relies on a diversified portfolio of CNS agents, which mitigates development risks. The humanitarian status of biomedicine provides Bionomics Limited (BNOX) with resilience against geopolitical upheavals and external sanction pressures.

Wutah bathi saben saham ing taun lumaku: Bionomics Ltd. (BNOX) kanggo 04.07.2022 - 24.12.2024

Rincian metrik keuangan lan pasar bionomics.com.au (BNOX)

- nilai pasar lan prakiraan target analis:
Ringkesan analisis perusahaan:BNOX Bionomics Ltd
Produk mawa merek Bionomics

Patent protection for Bionomics Limited (BNOX) developments in the CNS field lays the foundation for future margins and cash flows. The annual change in EPS measures the dynamics of net profit per share over a year, allowing for the tracking of business capitalization rates. Sharp peaks on this chart signal that the asset is overheated, while stagnation indicates a risk of capital stagnation and an overvalued security.